What is Agios Pharmaceuticals's price / earnings?

Agios Pharmaceuticals (AGIO) reported price / earnings of 3.7× in Q3 2024.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Agios Pharmaceuticals AGIO Price / earnings

Price / earnings at other companies

Bristol-Myers SquibbBMY

17×-6.2×

PfizerPFE

14.7×—

Vertex PharmaceuticalsVRTX

26.1×—

IncyteINCY

13.1×-538×

BioMarin PharmaceuticalsBMRN

20×-21.5×

BioCryst PharmaceuticalsBCRX

6.2×—

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

market cap/net income=3.7×

Based on the most recent quarter.

The official record: Agios Pharmaceuticals’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's price / earnings?: Agios Pharmaceuticals (AGIO) reported price / earnings of 3.7× in Q3 2024.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.